The Burden of Cardiovascular Disease in the Post-COVID Era

Area of Science:

• Public Health
• Cardiology
• Epidemiology

Background:

• Cardiovascular disease (CVD) was the leading cause of death in the US prior to 2019.
• The COVID-19 pandemic has significantly altered healthcare delivery, including cardiovascular care.
• Declines in US life expectancy may be linked to pandemic-related disruptions in CVD prevention and risk factor management.

Purpose of the Study:

• To review the impact of SARS-CoV-2 and the COVID-19 pandemic on cardiovascular disease risk factor prevention and management in the United States.
• To identify challenges and propose potential solutions for patients affected by these disruptions.

Main Methods:

• Literature review of studies published since 2020 focusing on the pandemic's effects on cardiovascular health.
• Analysis of disruptions in primary and secondary CVD prevention strategies.
• Examination of the control of major CVD risk factors during the pandemic.

Main Results:

• The pandemic led to significant disruptions in routine cardiovascular care and screenings.
• Management of key CVD risk factors such as hypertension, diabetes, and hyperlipidemia was negatively impacted.
• Delayed diagnoses and reduced adherence to treatment regimens were observed, potentially exacerbating CVD outcomes.

Conclusions:

• The COVID-19 pandemic has posed substantial challenges to cardiovascular disease prevention and management in the US.
• Addressing these challenges requires innovative strategies to restore and enhance CVD care.
• Future efforts should focus on mitigating the long-term cardiovascular consequences of the pandemic.